Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines

This publication has 33 references indexed in Scilit:

• Biochemical mechanisms of interferon modulation of 5-fluorouracil activity in colon cancer cells
  European Journal Of Cancer, 1997
• Computerized Quantitation of Synergism and Antagonism of Taxol, Topotecan, and Cisplatin Against Human Teratocarcinoma Cell Growth: a Rational Approach to Clinical Protocol Design
  JNCI Journal of the National Cancer Institute, 1994
• 2′,2′-Difluoro-deoxycytidine (gemcitabine) incorporation into RNA and DNA of tumour cell lines
  Biochemical Pharmacology, 1993
• Transformation of mouse fibroblasts with the oncogenes H-ras ortrk is associated with pronounced changes in drug sensitivity and metabolism
  International Journal of Cancer, 1993
• Cisplatin resistance in human cancers
  Pharmacology & Therapeutics, 1991
• Clinical Pharmacokinetics of Carboplatin
  Clinical Pharmacokinetics, 1991
• Platinum—DNA damage in leukocyte DNA of patients receiving carboplatin and cisplatin chemotherapy, measured by atomic absorption spectrometry
  Carcinogenesis: Integrative Cancer Research, 1991
• Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines
  JNCI Journal of the National Cancer Institute, 1991
• Synthesis of 2-deoxy-2,2-difluoro-D-ribose and 2-deoxy-2,2'-difluoro-D-ribofuranosyl nucleosides
  The Journal of Organic Chemistry, 1988
• Purine nucleosides as cell-specific modulators of 5-fluorouracil metabolism and cytotoxicity
  European Journal of Cancer and Clinical Oncology, 1987